Mechanism of E2F1-induced apoptosis in primary vascular smooth muscle cells

Cardiovascular Research

Volumn 59, Issue 2, 2003, Pages 512-519

  Stanelle, Jens ^a   Stiewe, Thorsten ^a,b   Rödicker, Florian ^a   Köhler, Karin ^a,c   Theseling, Carmen ^a   Pützer, Brigitte M ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Apoptosis; Gene expression; Gene therapy; Protein phosphorylation; Restenosis

Indexed keywords

ARF PROTEIN; PROTEIN P53; PROTEIN P73; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENETIC STRAIN; HUMAN; HUMAN CELL; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VASCULAR SMOOTH MUSCLE;

EID: 0142090552     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00392-4     Document Type: Article

References (38)

1. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12:1998;2245-2262.
2. Nevins J.R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:1998;585-593.
3. Shan B., Lee W.H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol. 14:1994;8166-8173.
4. Kowalik T.F., DeGregori J., Schwarz J.K., Nevins J.R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol. 69:1995;2491-2500.
5. DeGregori J., Leone G., Miron A., Jakoi L., Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA. 94:1997;7245-7250.
6. Phillips A.C., Stewart S., Ryan K.M., Helin K., Vousden K.H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11:1997;1853-1863.
7. Hsieh J.K., Fredersdorf S., Kouzarides T., Martin K., Lu X. E2F-1 induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11:1997;1840-1852.
8. Kowalik T.F., DeGregori J., Leone G., Jakoi L., Nevins J.R. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ. 9:1998;113-118.
9. Bates S., Phillips A.C., Clark P.A., et al. p14ARF links the tumour suppressors RB and p53. Nature. 395:1998;124-125.
10. Rogoff H.A., Pickering M.T., Debatis M.E., Jones S., Kowalik T.F. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol Cell Biol. 22:2002;5308-5318.
11. Hsieh J.K., Yap D., O'Connor D.J., et al. Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol Cell Biol. 22:2002;78-93.
12. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev. 8:1998;28-35.
13. Holmberg C., Helin K., Sehested M., Karlstrom O. E2F-1 induced p53-independent apoptosis in transgenic mice. Oncogene. 17:1998;143-155.
14. Haas-Kogan D.A., Kogan S.C., Levi D., et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:1995;461-472.
15. Krek W., Xu G., Livingston D.M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S-phase checkpoint. Cell. 83:1995;1149-1158.
16. Zacksenhaus E., Jiang Z., Phillips R.A., Gallie B. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product. EMBO J. 15:1996;5917-5927.
17. Stiewe T., Pützer B.M. Role of the p53 homolog p73 for E2F1-induced apoptosis. Nat Genet. 26:2000;464-469.
18. Irwin M., Martin M.C., Phillips A.C., et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature. 407:2000;645-648.
19. Moroni M.C., Hickman E.S., Denchi E.L., et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol. 3:2001;552-558.
20. Phillips A.C., Ernst M.K., Bates S., Rice N.R., Vousden K.H. E2F1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell. 4:1999;771-781.
21. Morishita R., Gibbons G.H., Horiuchi M., et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA. 92:1995;5855-5859.
22. Shelat H.S., Liu T.J., Hickman-Bick D.L., et al. Growth suppression of human coronary vascular smooth muscle cells by gene transfer of the transcription factor E2F1. Circulation. 103:2001;407-414.
23. Spyridopoulos J., Principe N., Krasinski K.L., et al. Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-α-induced apoptosis. Circulation. 98:1998;2883-2890.
24. Pützer B.M., Stiewe T., Crespo F., Esche H. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy. Gene Ther. 7:2000;1317-1325.
25. Stiewe T., Zimmermann S., Frilling A., Esche H., Pützer B.M. Transactivation-deficient ΔN-p73 acts as an oncogene. Cancer Res. 62:2002;3598-3602.
26. Ormerod M.G., Sun X.-M., Brown D., Snowden R.T., Cohen G.M. Quantification of apoptosis and necrosis by flow cytometry. Acta Oncol. 32:1993;417-424.
27. Wu X., Levine A.J. P53 and E2F1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA. 91:1994;3602-3606.
28. Qin X.Q., Livingston D.M., Kaelin W.G., Adams P. Deregulated E2F1 expression leads to S phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA. 91:1994;10918-10922.
29. Stanelle J., Stiewe T., Theseling C.C., Peter M., Pützer B.M. Gene expression changes in response to E2F1 activation. Nucleic Acids Res. 30:2002;1859-1867.
30. DeGregori J., Kowalik T., Nevins J.R. Cellular targets for activation of E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol. 15:1995;4215-4224.
31. Vigo E., Müller H., Prosperini E., et al. CDC25A phosphatase is a target of e2F and is required for efficient E2F-induced S phase. Mol Cell Biol. 19:1999;6379-6395.
32. Agah R., Kirshenbaum L.A., Abdellatif M., et al. Adenoviral delivery of E2F1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest. 100:1998;2722-2728.
33. Hunt K.K., Deng J., Liu T.J., et al. Adenovirus-mediated overexpression of the transcription factor E2F1 induces apoptosis in human breast cancer and ovarian carcinoma cell lines and does not require p53. Cancer Res. 57:1997;4722-4726.
34. Dimri G.P., Hara E., Campisi J. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts. J Biol Chem. 296:1994;16180-16186.
35. Lomarri M., Moroni M.C., Jensen M.R., Frittoli E., Helin K. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry. Nat Genet. 31:2002;190-194.
36. Aoki M., Morishita R., Matsushita H., et al. Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. Hypertension. 34:1999;192-200.
37. Johnson D.G., Schwarz J.K., Cress W.D., Nevins J.R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature. 365:1993;349-352.
38. Harbour J.W., Dean D.C. The RB/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14:2000;2393-2409.